A carregar...
Comparison of malaria treatment outcome of generic and innovator’s anti-malarial drugs containing artemether–lumefantrine combination in the management of uncomplicated malaria amongst Tanzanian children
BACKGROUND: In 2006, artemether–lumefantrine (ALU), specifically Coartem(®) (Novartis Pharma AG, Basel Switzerland), was approved as the first-line drug for treatment of uncomplicated malaria in Tanzania. Due to poor availability and affordability of the innovator’s product, the government of Tanzan...
Na minha lista:
| Publicado no: | Malar J |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6460845/ https://ncbi.nlm.nih.gov/pubmed/30975147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-019-2769-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|